Pfizer sells £3B of shares in Haleon (NYSE:PFE)
Pfizer (NYSE:PFE) has sold over £3 billion ($3.8 billion) of shares in Haleon (NYSE:HLN), thereby reducing its interest in the consumer health firm from 32% to approximately 22.6%. The U.S. drugmaker sold around 790.55M Haleon (HLN)…